BioSpace News Archive

Business

CellGenix Appoints Dr. Udo Nirenberg as Vice President Quality Management and Member of the Management Team

CellGeni is pleased to announce the appointment of Dr. Udo Nirenberg as Vice President of Quality Management and member of the management team.

November 15, 2018
·
2 min read
ADC Bio secures additional equity round investment

Extra funding for strategic move into downstream formulation and fill finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm

November 15, 2018
·
6 min read
Business

Invitation to presentation of Recipharm’s interim report for the third quarter 2018 on November 8

Recipharm will publish its interim report for January-September 2018 on the 8th November at 07:45 am CET.

November 15, 2018
·
1 min read
Drug Development

IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS AT THE BIO-EUROPE 24TH ANNUAL INTERNATIONAL PARTNERING CONFERENCE

iX Biopharma Ltd will be presenting the positive results from the Phase 2 clinical KET010 study for Wafermine, its lead product under development for the treatment of moderate to severe acute pain at the Bio-Europe 24th Annual International Partnering Conference in Copenhagen, Denmark.

November 15, 2018
·
3 min read
Business

Oxurion and Beta Therapeutics To Develop New Heparanase Inhibitors for Treatment of dry AMD

Oxurion NV announced today that it entered into a strategic research collaboration with Beta Therapeutics Pty Ltd

November 15, 2018
·
5 min read
MR Solutions shows new bench top CT preclinical scanner at nuclear medicine congress

MR Solutions shows new state-of-the-art bench top CT preclinical scanner with clip on PET and SPECT at nuclear medicine congress

November 15, 2018
·
2 min read
Business

One Busy Week for AbbVie: Hepatitis C, Fibroids, Alzheimer’s & Parkinson’s, and Generic Criticism

AbbVie presented additional data from two Phase III clinical trials in women with uterine fibroids. In a big news week for the company, what else is AbbVie up to?

November 15, 2018
·
4 min read
·
Mark Terry
Business

NantHealth Reports 2018 Third-Quarter Financial Results

Total Revenue in Q3 was $22.3 Million

November 15, 2018
·
20 min read
Business

Canada signs Memorandum of Understanding with 11 First Nations and Alberta towards full implementation of Jordan’s Principle

The Government of Canada, Government of Alberta and First Nations partners are working together to ensure that First Nations children in Alberta can access the supports and services they need, when they need them.

November 15, 2018
·
5 min read
Policy

Nexus Pharmaceuticals Receives FDA Approval for Arsenic Trioxide Injection in 10mg per 10mL Vial

Immediate Availability of 10mg per 10mL Vial of Generic Arsenic Trioxide for Intravenous Use

November 15, 2018
·
3 min read